Levacetam 250 Tablet contains Levetiracetam 250mg, an antiepileptic medication indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and pediatric patients. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit burst firing and reduce seizure activity. This mechanism contributes to its efficacy in controlling various seizure types with a favorable safety profile. Levacetam 250 is typically administered orally, with dosage individualized based on patient age, weight, renal function, and clinical response. Common adverse effects include somnolence, dizziness, headache, and fatigue, which are generally mild to moderate and transient. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Levacetem does not induce hepatic enzymes, minimizing drug-drug interactions, making it suitable for combination therapy with other antiepileptic drugs. Regular monitoring of clinical response and side effects is recommended to optimize therapy. Levacetem 250 Tablet should be used under the supervision of a healthcare professional, and patients should be advised not to discontinue therapy abruptly to avoid increased seizure risk.